FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Related Tags >> shareholders   restructuring   Trimeris   Novartis
Syndicate content

Martin Mattingly News

Most Popular Martin Mattingly Story

Going, going... Trimeris winds down ops

Faced with a patent fight that has frustrated efforts to find a buyer, Trimeris has begun to hand back out $80 million in cash as it winds down its operations. The Trimeris board has authorized... Read more...

Latest Headlines